LCN2 and liver dysplastic nodule: Urine biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and periostin, have shown potential as tools for the noninvasive monitoring of DN (V et al., 2024).